Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies

Journal of the American College of Cardiology

Volumn 65, Issue 18, 2015, Pages 1915-1928

  Maron, Barry J ^a   Rowin, Ethan J ^b   Casey, Susan A ^a   Link, Mark S ^b   Lesser, John R ^a   Chan, Raymond H M ^b   Garberich, Ross F ^a   Udelson, James E ^b   Maron, Martin S ^b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

heart failure; heart transplant; implantable defibrillators; sudden death

Indexed keywords

ADULT; ADULTHOOD; ADVERSE OUTCOME; AGE; AGED; ARTICLE; CARDIOEMBOLIC STROKE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LIFE THREAT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; SEX DIFFERENCE; SUDDEN CARDIAC DEATH; SURVIVAL RATE; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; HEART ATRIUM; LONGITUDINAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; STROKE; TACHYCARDIA, VENTRICULAR; UNITED STATES; VERY ELDERLY;

CARDIOTONIC AGENT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOTONIC AGENTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART ATRIA; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEX FACTORS; STROKE; TACHYCARDIA, VENTRICULAR; UNITED STATES;

EID: 84928969105     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.02.061     Document Type: Article

References (49)

1. B.J. Maron, S.R. Ommen, and C. Semsarian Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine J Am Coll Cardiol 64 2014 83 99
2. B.J. Maron, and M.S. Maron Hypertrophic cardiomyopathy Lancet 381 2013 242 255
3. B.J. Maron Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy Circulation 121 2010 445 456
4. C. O'Mahony, M. Tome-Esteban, and P.D. Lambiase A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy Heart 99 2013 534 541
5. B.J. Maron, W.J. McKenna, G.K. Danielson Task Force on Clinical Expert Consensus Documents. American College of Cardiology Committee for Practice Guidelines. European Society of Cardiology American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
6. B.J. Gersh, B.J. Maron, and R.O. Bonow 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons J Am Coll Cardiol 58 2011 e212 e260
7. P.M. Elliott, J. Poloniecki, and S. Dickie Sudden death in hypertrophic cardiomyopathy: identification of high risk patients J Am Coll Cardiol 36 2000 2212 2218
8. C. O'Mahony, F. Jichi, M. Pavlou Hypertrophic Cardiomyopathy Outcomes Investigators A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD) Eur Heart J 35 2014 2010 2020
9. B.J. Maron, I. Olivotto, and P. Spirito Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population Circulation 102 2000 858 864
10. B.J. Maron, and E. Braunwald Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease Circulation 126 2012 1640 1644
11. I. Christiaans, K. van Engelen, and I.M. van Langen Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers Europace 12 2010 313 321
12. B.J. Maron, P. Spirito, and W.K. Shen Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 2007 405 412
13. A.F. Schinkel, P.A. Vriesendorp, and E.J. Sijbrands Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis Circ Heart Fail 5 2012 552 559
14. P.A. Vriesendorp, A.F. Schinkel, and J. Van Cleemput Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications Am Heart J 166 2013 496 502
15. B.J. Maron, W.K. Shen, and M.S. Link Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy N Engl J Med 342 2000 365 373
16. K.M. Harris, P. Spirito, and M.S. Maron Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 11 2006 216 225
17. M.S. Maron, B.M. Kalsmith, and J.E. Udelson Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy Circ Heart Fail 3 2010 574 579
18. T.S. Kato, H. Takayama, and S. Yoshizawa Cardiac transplantation in patients with hypertrophic cardiomyopathy Am J Cardiol 110 2012 568 574
19. B.J. Maron, E.J. Rowin, and S.A. Casey Risk stratification and outcome of patients with hypertrophic cardiomyopathy ≥ 60 years of age Circulation 127 2013 585 593
20. Dutchen S. Silencing Sudden Death. Harvard Medical School News. October 3, 2013. Available at: http://hms.harvard.edu/news/genetics/silencing-sudden-death-10-3-13. Accessed March 6, 2013.
21. M.S. Maron, B.J. Maron, and C. Harrigan Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 220 228
22. M.S. Maron, I. Olivotto, and A.G. Zenovich Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction Circulation 114 2006 2232 2239
23. M.Y. Desai, A. Bhonsale, and P. Patel Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes J Am Coll Cardiol Img 7 2014 26 36
24. R.H. Chan, B.J. Maron, and I. Olivotto Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy Circulation 130 2014 484 495
25. Centers for Disease Control and Prevention Vital Statistics of the United States, 1995, preprint of volume II, Mortality, part A, section 6 Life Tables 1998 CDC/National Center for Health Statistics Hyattsville, MD
26. T.M. Therneau, and P.M. Grambsch Modeling Survival Data: Extending the Cox Model 2000 Springer New York, NY 16 17
27. M.S. Maron, J.J. Finley, and J.M. Bos Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy Circulation 118 2008 1541 1549
28. P. Spirito, C. Autore, and F. Formisano Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors Am J Cardiol 113 2014 1550 1555
29. B.J. Maron, M.S. Maron, and J.R. Lesser Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status Am J Cardiol 101 2008 544 547
30. B.J. Maron, M.S. Maron, and B.A. Maron Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 57 2011 2454 2456
31. S.R. Ommen, B.J. Maron, and I. Olivotto Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 46 2005 470 476
32. P. Sorajja, S.R. Ommen, and D.R. Holmes Jr. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy Circulation 126 2012 2374 2380
33. B.J. Maron, P. Spirito, and M.J. Ackerman Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy J Am Coll Cardiol 61 2013 1527 1535
34. W.J. McKenna, and J.E. Deanfield Hypertrophic cardiomyopathy: an important cause of sudden death Arch Dis Child 59 1984 971 975
35. B.J. Maron, W.L. Henry, and C.E. Clark Asymmetric septal hypertrophy in childhood Circulation 53 1976 9 19
36. P.M. Shah, A.G. Adelman, and E.D. Wigle The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy Circ Res 35 Suppl II 1974 179 195
37. T. Hardarson, C.S. De la Calzada, and R. Curiel Prognosis and mortality of hypertrophic obstructive cardiomyopathy Lancet 2 1973 1462 1467
38. P. Spirito, F. Chiarella, and L. Carratino Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population N Engl J Med 320 1989 749 755
39. B.J. Maron, S.A. Casey, and L.C. Poliac Clinical course of hypertrophic cardiomyopathy in a regional United States cohort JAMA 281 1999 650 655
40. M.T. Wheeler, and E.A. Ashley Hypertrophic cardiomyopathy: can the horse be put back in the barn? J Am Coll Cardiol 65 2015 570 572
41. G.H. Bardy, K.L. Lee, D.B. Mark Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
42. A.J. Moss, W.J. Hall, and D.S. Cannom Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia N Engl J Med 335 1996 1933 1940
43. P.M. Elliott, A. Anastasakis, and M.A. Borger 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J 35 2014 2733 2779
44. A. Kadish, A. Dyer, J.P. Daubert Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
45. B.J. Maron, and P. Spirito Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy J Cardiovasc Electrophysiol 19 2008 1118 1126
46. C.J. McLeod, S.R. Ommen, and M.J. Ackerman Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy Eur Heart J 28 2007 2583 2588
47. B.J. Maron Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy Circulation 116 2007 196 206
48. B.J. Maron, H. Rastegar, and J.E. Udelson Contemporary surgical management of hypertrophic cardiomyopathy, the need for more myectomy surgeons and disease-specific centers, and the Tufts initiative Am J Cardiol 112 2013 1512 1515
49. B.J. Maron Hypertrophic cardiomyopathy centers Am J Cardiol 104 2009 1158 1159